SCHEMBL25815860

SCHEMBL25815860

CN1CCCc2c(Br)cccc2C1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.51
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
PRMT6 Q96LA8 1/20 0.44
PRMT1 Q99873 1/20 0.44
DRD1 P21728 6/20 0.43
DRD5 P21918 5/20 0.43
ABHD6 Q9BV23 3/20 0.42
AKR1C3 P42330 1/20 0.41
DRD2 P14416 4/20 0.40
DRD3 P35462 4/20 0.40
DRD4 P21917 3/20 0.40
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16076617 0.89 MAOA (0.57) CARM1MAOAMAOBPRMT6PRMT1
SCHEMBL2647074 0.80 CARM1 (0.42) CARM1MAOAMAOBPRMT6PRMT1
SCHEMBL25819427 0.79 CARM1 (0.48) CARM1PRMT6PRMT1ABHD6AKR1C3
SCHEMBL3117967 0.79 MAOA (0.57) CARM1MAOAMAOBDRD1DRD5
SCHEMBL10696964 0.78 ADRA2A (0.61) CARM1MAOAMAOBPRMT6PRMT1
SCHEMBL26161466 0.77 MAOA (0.50) MAOAMAOBDRD1DRD5DRD2
Hydrochloric Acid SCHEMBL10990863 0.77 NPSR1 (0.62) CARM1MAOAMAOBPRMT6PRMT1
SCHEMBL1950767 0.75 MAOA (0.75) MAOAMAOBDRD1DRD5DRD2
SCHEMBL19643944 0.74 CARM1 (0.42) CARM1PRMT6PRMT1ABHD6AKR1C3
SCHEMBL24425269 0.74 MAOA (0.46) MAOAMAOBDRD1DRD5DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219923-A1 KINASE INHIBITORS VIDYA THERAPEUTICS, INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219923-A1 KINASE INHIBITORS BTK, ABL1, LYN CARM1 1821/4885MAOA 1167/4885MAOB 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.